Home
News
Your Voice
Links
Jobs
Sitemap
Contact
YOU ARE HERE: >
Kernow Clinical Commissioning Group
>
Formulary Information
>
Information Page
Home
Drugs
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Chapters
KCC Referral
Management System
Shared Care
Guidelines
Care Home
Resources
Local Resource
Packs
Chronic Pain
in Cornwall
Diabetes Resources
Respiratory Resources
Flu Resource Pack
Patient Group Direction (PGD)
Palliative Care Resources
Search
Search Drugs
Search BNF Categories
Notes
Click to View ALL BNF
Ch1 Gastro
Ch2 Cardio
Ch3 Respiratory
Ch4 CNS
Ch5 Infections
Ch6 Endocrine
Ch7 Obs & Gynae
Ch8 Malignant Disease
Ch9 Nutrition & Blood
Ch10 Muscuskeletal
Ch11 Eye
Ch12 Ear, Nose, Oropharynx
Ch13 Skin
Ch14 Immunological
Ch15 Anaesthesia
Ch19 Other Dugs
ch20 Dressings
ch21 Appliances
ch22 Incontinence appliances
ch23 Stoma appliances
>>
1. Drugs Used In Diabetes
2. Thyroid And Antithyroid Drugs
3. Corticosteroids (Endocrine)
4. Sex Hormones
5. Hypothalamic&Pituitary Hormones&Antioest
6. Drugs Affecting Bone Metabolism
7. Other Endocrine Drugs
>>
1. Short-Acting Insulins
2. Intermediate And Long-Acting Insulins
3. Hypodermic equipment
1. Sulfonylureas
2. Biguanides
3. Other Antidiabetics
0. Treatment Of Hypoglycaemia
0. Treatment of diabetic nephropathy and neuropathy
0. Screening and Monitoring Agents
(Click to View Drug List)
Cost
Cost
Packs
Packs
Items
Items
Loading…
Summary:
Formulary Notes (BNF Chapter)
Formulary Notes (BNF Chapter)
Formulary Notes (BNF Section)
Formulary Notes (BNF Section)
NICE Guidance (12)
NICE Guidance (12)
Other Links (7)
Other Links (7)
Important Local Documents (12)
Important Local Documents (12)
Notes for: Endocrine system
Last edited [21/09/2023 11:43:40]
NICE NG28 Type 2 diabetes in adults: management
NICE NG17 Type 1 diabetes in adults: diagnosis and management
NG18 Diabetes (type 1 and type 2) in children and young people
: diagnosis and management
Medication
for
fertility
treatment
-
guidance
for
primary
care prescribers
NHS
Kernow
updated
guidance
for
prescribing
of
SGLT2
inhibitors May 2022
Glucagon-like
peptide
-1 (GLP-1) analogue factsheet 2022
Information for people with questions about the availability of the new medicine Wegovy® (semaglutide)
Semaglutide
(
Ozempic)
setting
pre
-
set
quantities in
GP
pr
actice systems to prevent overprescribing
Notes for: Drugs Used In Diabetes
Last edited [20/09/2021 12:13:34]
NICE Guidance (BNF Section Level) for - Drugs Used In Diabetes
15/07/2020
All NICE products (guidance etc.) on diabetes.
15/07/2020
PCOS metformin in women not planning pregnancy
12/05/2021
TA679 Dapagliflozin for treating chronic heart failure with reduced ejection fraction
13/05/2021
TA664 Liraglutide for managing overweight and obesity
20/09/2021
NG18 Diabetes (type 1 and type 2) in children and young people: diagnosis and management
20/09/2021
NG28 Type 2 diabetes in adults: management
20/09/2021
NG17 Type 1 diabetes in adults: diagnosis and management
15/03/2022
TA775 Dapagliflozin for treating chronic kidney disease
13/05/2022
TA773 Empagliflozin for treating chronic heart failure with reduced ejection fraction
28/06/2023
TA902 Dapagliflozin for treating chronic heart failure with preserved or mildly reduced ejection fraction
NICE Guidance (BNF Chapter Level) for - Endocrine system
18/05/2023
Somatrogon for treating growth disturbance in children and young people aged 3 years and over NICE TA 863
16/08/2023
Semaglutide for managing overweight and obesity NICE TA875
Other links (BNF Section Level) for - Drugs Used In Diabetes
22/05/2015
DSU Apr 15 - High strength, fixed combination and biosimilar insulin products: minimising the risk of medication error
15/07/2020
SGLT2 inhibitors: updated advice on the risk of diabetic ketoacidosis
15/07/2020
Canagliflozin (Invokana, Vokanamet): signal of increased risk of lower extremity amputations observed in trial in high cardiovascular risk patients
15/07/2020
SGLT2 inhibitors: reports of Fournier’s gangrene (necrotising fasciitis of the genitalia or perineum)
15/07/2020
SGLT2 inhibitors: monitor ketones in blood during treatment interruption for surgical procedures or acute serious medical illness
30/09/2020
DSU Sept 2020 Insulins (all types): Risk of cutaneous amyloidosis at injection site
Other Links (BNF Chapter Level) for - Endocrine system
31/10/2022
NHS Cornwall Commissioning policies 2022 to 2023
Important Local Documents (BNF Sub Paragraph Level) for - Intermediate And Long-Acting Insulins
10/06/2014
Guidelines for initiation of insulin
Important Local Documents (BNF Chapter Level) for - Endocrine system
09/11/2018
KCCG Insulin Factsheet (Type 2 Diabetes)
09/11/2018
KCCG Metformin Factsheet
23/10/2020
NHS Kernow lancets factsheet September 2020
19/11/2021
NHS Kernow home blood glucose testing leaflet October 2021
27/05/2022
NHS Kernow updated guidance for prescribing of SGLT2 inhibitors May 2022
31/10/2022
Glucagon-like peptide-1 (GLP-1) analogue factsheet 2022
10/03/2023
Insulin needle factsheet Cornwall ICB
09/11/2018
KCCG Gliptins Factsheet
08/06/2023
Information for people with questions about the availability of the new medicine Wegovy® (semaglutide)
10/08/2020
NHS Kernow diabetes and frailty guidance June 2020
07/10/2021
NHS Kernow guidelines for blood glucose monitoring in adults 2021
Loading…
Cornwall Joint Formulary Recommended Choices
(...Top)
Displaying 25 Drugs
Key:
First Line Drugs
Second Line Drugs
Specialist Initiated Drugs
Hospital Only Drugs
Discouraged
No comment available
Antibiotics
Name
Tariff
BNF Sub Paragraph
Insulin isophane human
10 units/ml suspension for injection 10ml vials Pack of 1
£7.48
Intermediate And Long-Acting Insulins
Humulin I Vial
10 ml Vial (100units / ml) Pack of 1
£15.68
Intermediate And Long-Acting Insulins
Humulin M3 Vial
10 ml Vial (100units / ml) Pack of 1
£15.68
Intermediate And Long-Acting Insulins
Humulin I Cartridge
3 ml Cartridge Pack of 5
£19.08
Intermediate And Long-Acting Insulins
Insulatard InnoLet (Insulin Isophane Human)
100 units/ml suspension - 3ml pre-filled pens Pack of 5
£20.40
Intermediate And Long-Acting Insulins
Humulin I Preloaded Pen
3 ml Disposable Pen (kwikpen) Pack of 5
£21.70
Intermediate And Long-Acting Insulins
Humulin M3 Preloaded Pen
3 ml Disposable Pen (kwikpen) Pack of 5
£21.70
Intermediate And Long-Acting Insulins
Insulin Isophane Human (Insulatard Penfill)
100 units/ml suspension for injection 3ml cartridge Pack of 5
£22.90
Intermediate And Long-Acting Insulins
NovoMix 30 Cartridge (Penfill)
3 ml penfill cartridge Pack of 5
£28.79
Intermediate And Long-Acting Insulins
Humalog Mix25 Cartridge
3 ml Cartridge Pack of 5
£29.46
Intermediate And Long-Acting Insulins
NovoMix 30 Prefilled Pen (FlexPen )
3 ml pre-filled pen Pack of 5
£29.89
Intermediate And Long-Acting Insulins
Humalog Mix25 Prefilled Pen
3 ml Disposable Pen Pack of 5
£30.98
Intermediate And Long-Acting Insulins
Insulin glargine (Abasaglar)
100 units/ml solution for injection 3ml cartridges Pack of 5
£35.28
Intermediate And Long-Acting Insulins
Insulin glargine (Abasaglar KwikPen)
100 units/ml solution for injection 3ml pre-filled pen Pack of 5
£35.28
Intermediate And Long-Acting Insulins
Insulin Detemir (Levemir Penfill)
3 ml cartridge Pack of 5
£42.00
Intermediate And Long-Acting Insulins
Insulin Detemir (Levemir Flexpen)
3 ml preloaded pen Pack of 5
£42.00
Intermediate And Long-Acting Insulins
Insulin Detemir (Levemir Innolet)
3 ml prefilled pen Pack of 5
£44.85
Intermediate And Long-Acting Insulins
Insulin Glargine (Lantus)
10 ml vial (100units / ml) Pack of 1
£25.69
Intermediate And Long-Acting Insulins
Insulin Glargine (Lantus)
3 ml cartridge (for OptiPen / Autopen) Pack of 5
£34.75
Intermediate And Long-Acting Insulins
Insulin Glargine (Lantus)
3 ml SoloStar pen Pack of 5
£34.75
Intermediate And Long-Acting Insulins
Insulin Glargine (Lantus)
3 ml OptiSet pen Pack of 5
£41.50
Intermediate And Long-Acting Insulins
Insulin Degludec (Tresiba)
100 u / ml (3ml cartridge) (Penfill) Pack of 5
£40.00
Intermediate And Long-Acting Insulins
Insulin degludec (Tresiba) Consultant initiated - approved for use in the treatment of type 1 diabetes mellitus in adults, adolescents and children from the age of one year, who are under the care of the paediatric diabetes service
Insulin Degludec (Tresiba Flextouch)
100 u/ml (3ml prefilled pen) Pack of 5
£46.60
Intermediate And Long-Acting Insulins
Insulin degludec (Tresiba) Consultant initiated - approved for use in the treatment of type 1 diabetes mellitus in adults, adolescents and children from the age of one year, who are under the care of the paediatric diabetes service
Insulin Degludec (Tresiba Flextouch)
200 u/ml (3ml prefilled pen) Pack of 3
£55.92
Intermediate And Long-Acting Insulins
Insulin degludec (Tresiba) Consultant initiated - approved for use in the treatment of type 1 diabetes mellitus in adults, adolescents and children from the age of one year, who are under the care of the paediatric diabetes service.
Insulin degludec / Liraglutide (Xultophy)
100 units/ml/Liraglutide 3.6mg/ml solution for injection 3ml pre-filled pen Pack of 5
£159.22
Intermediate And Long-Acting Insulins
Xultophy, a combination of liraglutide/insulin degludec, is accepted onto the formulary for patients intolerant of at least two GLP-1 agonists and who may also be on insulin. Prescribing of Xultophy will be undertaken by the Diabetes Team for the first month and guidance on how Xultophy will be titrated up (and any existing insulin titrated down) will be provided by the Diabetes Team. Patients on Xultophy will be supervised by the Team for about 12 months.
© Kernow Clinical Commissioning Group 2023 - All Rights Reserved
The Sedgemoor Centre, Priory Road, St Austell, Cornwall, PL25 5AS